Charter Medical

Executive Summary

Charter Medical, founded in 1989 and headquartered in Winston-Salem, NC, is a privately held leader in custom single-use solutions for bioprocessing, cell therapy, blood transfusions, and filtration. The company designs and manufactures innovative, integrated systems that help biopharmaceutical and medical device customers reduce contamination risk, improve operational efficiency, and accelerate time-to-market. With the global bioprocessing market expanding rapidly—driven by the rise of biologics, cell and gene therapies, and personalized medicine—Charter Medical is well-positioned to capture share. Its long-standing expertise, established customer relationships, and focus on custom solutions differentiate it from larger competitors in a fragmented industry. Looking ahead, Charter Medical's growth trajectory is supported by several near-term catalysts. The introduction of next-generation single-use bioreactor systems is expected to enhance its product portfolio and attract new customers. Additionally, a potential strategic partnership with a leading cell therapy developer could unlock significant revenue opportunities. The company is also investing in expanded manufacturing capacity to meet rising demand for filtration products. While private and not widely covered, Charter Medical's niche focus and proven track record suggest a solid foundation for sustained growth and market relevance.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation single-use bioreactor systems70% success
• Q4 2026Strategic partnership with a major cell therapy developer60% success
• Q2 2026Expansion of manufacturing capacity for filtration products80% success